We are live on
!
Find out more
Stephens Investment Management Group Portfolio holdings
AUM
$9.33B
Turnover
13.37%
1-Year Est. Return
56.1%
This Fund
S&P 500
This Quarter
Est. Return
+13.76%
1 Year Est. Return
+56.1%
3 Year Est. Return
+159.94%
5 Year Est. Return
+193.56%
10 Year Est. Return
+1,178.18%
AUM
$5.42B
AUM Growth
+$444M
(+8.9%)
Cap. Flow
-$140M
Cap. Flow
% of AUM
-2.59%
Top 10 Holdings %
Top 10 Hldgs %
15.44%
Holding
190
New
11
Increased
75
Reduced
89
Closed
8
Avg Time Held
3.1
years
Top 10 Avg Time Held
1.1
years
Top 20 Avg Time Held
1.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BioTelemetry, Inc.
BEAT
|
+$24.9M |
| 2 |
Grand Canyon Education
LOPE
|
+$14.7M |
| 3 |
Limoneira
LMNR
|
+$12M |
| 4 |
Encore Capital Group
ECPG
|
+$11.1M |
| 5 |
CSOD
Cornerstone OnDemand, Inc.
CSOD
|
+$9.74M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chuy's Holdings, Inc. Common Stock
CHUY
|
+$33M |
| 2 |
ABMD
Abiomed Inc
ABMD
|
+$22.4M |
| 3 |
AeroVironment
AVAV
|
+$14.9M |
| 4 |
RTEC
Rudolph Technologies Inc
RTEC
|
+$12.7M |
| 5 |
Power Integrations
POWI
|
+$12.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.36% |
| 2 | Healthcare | 21.55% |
| 3 | Industrials | 19.75% |
| 4 | Consumer Discretionary | 8.99% |
| 5 | Financials | 5.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Ligand Pharmaceuticals
LGND
$5.95B
| $105M | 1.94% |
613,040
-53,553
| -8% | -$8.07M |
2013 Q3
20 quarters
|
|
2
Icon
ICLR
$13.5B
| $92.6M | 1.71% |
601,973
-17,040
| -3% | -$2.44M |
2013 Q2
21 quarters
|
|
3
Protolabs
PRLB
$2.09B
| $90.2M | 1.66% |
557,886
-41,317
| -7% | -$5.85M |
2013 Q2
21 quarters
|
|
4
DELISTED
ASPEN TECHNOLOGY INC
AZPN
| $89.1M | 1.64% |
782,248
-28,047
| -3% | -$3.19M |
2013 Q2
21 quarters
|
|
5
Ollie's Bargain Outlet
OLLI
$5.68B
| $81M | 1.49% |
842,474
-12,120
| -1% | -$968K |
2016 Q2
9 quarters
|
|
6
CoStar Group
CSGP
$13B
| $79M | 1.46% |
1,876,060
-199,600
| -10% | -$8.53M |
2013 Q2
21 quarters
|
|
7
WEX
WEX
$6.17B
| $76M | 1.4% |
378,391
-7,670
| -2% | -$1.47M |
2014 Q4
15 quarters
|
|
8
HEICO Corp Class A
HEI.A
$32.3B
| $75.9M | 1.4% |
1,004,906
-29,507
| -3% | -$2.03M |
2016 Q2
9 quarters
|
|
9
Wingstop
WING
$3.57B
| $74.7M | 1.38% |
1,094,292
-36,854
| -3% | -$2.22M |
2016 Q2
9 quarters
|
|
10
Take-Two Interactive
TTWO
$39.1B
| $73.8M | 1.36% |
534,712
-3,941
| -0.7% | -$503K |
2016 Q4
7 quarters
|
|
|
ABMD
11
DELISTED
Abiomed Inc
ABMD
| $72.1M | 1.33% |
160,340
-56,735
| -26% | -$22.4M |
2015 Q1
14 quarters
|
|
12
DELISTED
Ultimate Software Group Inc
ULTI
| $71.5M | 1.32% |
221,854
-15,665
| -7% | -$4.64M |
2013 Q2
21 quarters
|
|
|
FLIR
13
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
| $71.3M | 1.32% |
1,160,278
-28,484
| -2% | -$1.68M |
2014 Q1
18 quarters
|
|
14
DELISTED
The Aaron's Company Inc Class A
AAN.A
| $70.4M | 1.3% |
1,293,324
-39,842
| -3% | -$2.17M |
2015 Q3
12 quarters
|
|
15
HealthEquity
HQY
$7.65B
| $68.9M | 1.27% |
730,030
-18,692
| -2% | -$1.61M |
2014 Q3
16 quarters
|
|
16
Semtech
SMTC
$13.5B
| $68.7M | 1.27% |
1,234,808
-34,254
| -3% | -$1.79M |
2013 Q2
21 quarters
|
|
17
Idexx Laboratories
IDXX
$43.1B
| $67.4M | 1.24% |
269,788
-7,894
| -3% | -$1.92M |
2013 Q2
21 quarters
|
|
|
PFPT
18
DELISTED
Proofpoint, Inc.
PFPT
| $66.5M | 1.23% |
625,274
-39,135
| -6% | -$4.55M |
2013 Q3
20 quarters
|
|
19
DELISTED
Calavo Growers
CVGW
| $65.6M | 1.21% |
679,457
-20,148
| -3% | -$1.99M |
2015 Q1
14 quarters
|
|
20
Guidewire Software
GWRE
$14.4B
| $64.1M | 1.18% |
634,735
-86,580
| -12% | -$8.32M |
2014 Q2
17 quarters
|
|
|
SIVB
21
DELISTED
SVB Financial Group
SIVB
| $63.5M | 1.17% |
204,176
-5,143
| -2% | -$1.62M |
2013 Q2
21 quarters
|
|
22
Angi Inc
ANGI
$262M
| $62.5M | 1.15% |
266,068
-8,920
| -3% | -$1.72M |
2017 Q2
5 quarters
|
|
23
Neogen
NEOG
$2.68B
| $62M | 1.14% |
1,734,144
-103,582
| -6% | -$4.42M |
2013 Q2
21 quarters
|
|
24
Illumina
ILMN
$40.5B
| $61.6M | 1.14% |
172,479
-8,325
| -5% | -$2.67M |
2013 Q2
21 quarters
|
|
25
Pacira BioSciences
PCRX
$1.45B
| $60.4M | 1.11% |
1,228,489
+30,218
| +3% | +$1.31M |
2013 Q2
21 quarters
|
|
Similar funds
Stephens Investment Management Group's Q3 2018 Portfolio in Review
As of Q3 2018, Stephens Investment Management Group held 190 positions worth $5.42B, up 8.9% from $4.98B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Stephens Investment Management Group's Q3 2018 filing shows 11 new, 75 increased, 89 reduced and 8 closed positions. Its largest new stake was BioTelemetry, Inc.: 447,097 shares worth $28.8M. The largest sale was Chuy's Holdings, Inc. Common Stock, an estimated $33M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Healthcare and Industrials.
- Stephens Investment Management Group's largest Q3 2018 buy was BioTelemetry, Inc.: 447,097 shares worth $28.8M.
- Stephens Investment Management Group added most to Rockwell Automation in Q3 2018, an estimated $7.84M increase.
- Stephens Investment Management Group's biggest Q3 2018 reduction was Abiomed Inc, cutting an estimated $22.4M.
- Stephens Investment Management Group fully exited Chuy's Holdings, Inc. Common Stock in Q3 2018, selling an estimated $33M.
- Stephens Investment Management Group's ten largest holdings make up 15% of its $5.42B portfolio in Q3 2018.
- Stephens Investment Management Group opened 11 new positions and closed 8 in Q3 2018.
- Stephens Investment Management Group's portfolio value rose 8.9% quarter-over-quarter to $5.42B.
Based on Stephens Investment Management Group's 13F filing for Q3 2018, filed 14 Nov 2018.